Minerva Neurosciences, Inc. (NERV)
NASDAQ·Healthcare·Biotechnology
$2.22
-0.45%
Mkt Cap $55.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+350.5%
Consensus $10.00 vs current $2.22
NASDAQ·Healthcare·Biotechnology
$2.22
-0.45%
Mkt Cap $55.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
+350.5%
Consensus $10.00 vs current $2.22